Prévisions du marché européen des organisations de vente sous contrat pharmaceutique jusqu’en 2030 – Analyse régionale – par services (services commerciaux et services non commerciaux), modules (modules syndiqués et modules dédiés), domaine thérapeutique (troubles cardiovasculaires, oncologie, troubles métaboliques, neurologie, maladies orthopédiques, Maladies infectieuses et autres) et utilisateur final (sociétés biopharmaceutiques et sociétés pharmaceutiques)

Le marché européen des organisations de vente sous contrat pharmaceutique devrait passer de 1 908,90 millions de dollars US en 2022 à 3 474,97 millions de dollars US d’ici 2030. Il devrait enregistrer un TCAC de 7,8 % de 2022 à 2030. Intérêt croissant des sociétés pharmaceutiques pour augmenter les ventes de Les produits stimulent le marché européen des organisations de vente de produits pharmaceutiques sous contrat Ces dernières années, les sociétés pharmaceutiques ont adopté de plus en plus de stratégies innovantes pour augmenter les ventes de leurs produits. Une tendance notable dans ce paysage est le recours accru aux organisations de vente sous contrat (OSC) pharmaceutiques comme élément essentiel de leurs efforts de commercialisation. Cela souligne une approche proactive de la part des entités pharmaceutiques pour naviguer dans les complexités du marché. En faisant appel aux OSC, ces entreprises peuvent faire appel à des forces de vente spécialisées, capitalisant sur les compétences externes pour améliorer leur pénétration du marché et optimiser leurs performances commerciales. Ce paradigme collaboratif permet aux sociétés pharmaceutiques de rationaliser leurs opérations et de se concentrer sur des compétences de base telles que la recherche et le développement, tout en tirant parti de l\'expertise personnalisée des OSC pour renforcer la présence de leurs produits sur le marché. La synergie croissante entre les sociétés pharmaceutiques et les OSC reflète une compréhension nuancée de l’optimisation des ressources, illustrant un engagement en faveur de l’adaptabilité et une conscience aiguë de l’évolution de la dynamique au sein d’un paysage pharmaceutique extrêmement concurrentiel. Cette relation symbiotique facilite la maximisation des revenus et positionne stratégiquement les entreprises pharmaceutiques dans un environnement où l\'agilité et les stratégies de marché ciblées sont primordiales pour un succès durable. Aperçu du marché européen des organisations de vente sous contrat pharmaceutique Le marché européen des organisations de vente sous contrat pharmaceutique est segmenté en Allemagne, au Royaume-Uni, en France, en Italie, en Espagne et dans le reste de l\'Europe. La demande de produits pharmaceutiques augmente considérablement dans cette région avec la prévalence croissante des maladies chroniques, l\'augmentation de la population gériatrique et la demande croissante de nouvelles molécules médicamenteuses pour diverses applications thérapeutiques afin de répondre à des besoins non satisfaits. Près de 550 sociétés pharmaceutiques sont implantées en Allemagne. Les organisations de vente sous contrat (OSC) de ce pays fournissent leurs services aux grandes sociétés pharmaceutiques et aux petites sociétés de biotechnologie, les aidant à atteindre des positions de leader sur le marché européen. Selon les données de Germany Trade & Invest, les ventes pharmaceutiques en Allemagne ont augmenté de 6,7 % en 2020 par rapport à 2019, atteignant 60,79 milliards de dollars américains (49,5 milliards d\'euros). Le paysage de l’industrie pharmaceutique en Allemagne et dans d’autres pays européens a récemment subi des changements importants en raison du développement de médicaments biologiques. En conséquence, les produits biologiques occupent une part importante des entreprises pharmaceutiques en raison de leur fort potentiel thérapeutique. Les grandes entreprises se concentrent désormais sur la création de composés biologiques complexes plutôt que sur le développement de médicaments à petites molécules. En mars 2021, IQVIA a travaillé avec Janssen Research & Development, LLC, l\'une des sociétés pharmaceutiques Janssen, filiale de Johnson & Johnson, sur les essais cliniques de phase 3 du vaccin COVID-19 de Janssen. Combinant technologies de télésanté, surveillance virtuelle et tactiques d\'interaction numérique avec les patients, les essais ont tiré parti de la gamme de solutions d\'essai décentralisées d\'IQVIA, soutenues par des études sur site et à distance. IQVIA possède la plus grande organisation de solutions commerciales au monde dédiée au lancement et à la commercialisation des produits de divers clients, et la société est présente dans divers pays européens. Chiffre d’affaires et prévisions du marché européen des organisations de vente sous contrat pharmaceutique jusqu’en 2030 (en millions de dollars américains) Segmentation du marché des organisations de vente sous contrat pharmaceutique en Europe Le marché européen des organisations de vente sous contrat pharmaceutique est segmenté en services, modules, domaine thérapeutique, utilisateur final et pays. Basé sur les services, le marché européen des organisations de vente sous contrat de produits pharmaceutiques est divisé en services commerciaux et services non commerciaux. Le segment des services commerciaux détenait une part plus importante du marché européen des organisations de vente sous contrat pharmaceutique en 2022. Sur la base des modules, le marché européen des organisations de vente sous contrat pharmaceutique est divisé en modules syndiqués et modules dédiés. Le segment des modules syndiqués détenait une part plus importante du marché européen des organisations de vente sous contrat pharmaceutique en 2022. Sur la base du domaine thérapeutique, le marché européen des organisations de vente sous contrat pharmaceutique est segmenté en troubles cardiovasculaires, oncologie, troubles métaboliques, neurologie, maladies orthopédiques, maladies infectieuses, et d\'autres. Le segment oncologie détenait la plus grande part du marché européen des organisations de vente sous contrat pharmaceutique en 2022. En fonction de l’utilisateur final, le marché européen des organisations de vente sous contrat pharmaceutique est divisé en sociétés biopharmaceutiques et sociétés pharmaceutiques. Le segment des sociétés pharmaceutiques détenait une part plus importante du marché européen des organisations de vente sous contrat pharmaceutique en 2022. En fonction des pays, le marché européen des organisations de vente sous contrat pharmaceutique est segmenté entre le Royaume-Uni, l’Allemagne, la France, l’Espagne, l’Italie et le reste de l’Europe. L\'Allemagne a dominé le marché européen des organisations de vente sous contrat pharmaceutique en 2022. Aenova Holding GmbH, IQVIA Holdings Inc, MaBico SA, Pfizer Inc et Syneos Health Inc font partie des principales sociétés opérant sur le marché européen des organisations de vente sous contrat pharmaceutique.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Pharmaceutical Contract Sales Organizations Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe PEST Analysis

5. Europe Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Integration of Digital Technologies

5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products

5.2 Key Market Restraints

5.2.1 Quality Issues Associated with Outsourcing

5.3 Key Market Opportunities

5.3.1 Rising Use of Telemedicine and Remote Detailing

5.4 Key Future Trends

5.4.1 Expansion in Emerging Markets

5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - Europe Market Analysis

6.1 Europe Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

7.1 Overview

7.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

7.3 Commercial Services

7.3.1 Overview

7.3.2 Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Non-Commercial Services

7.4.1 Overview

7.4.2 Non-Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

8.1 Overview

8.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

8.3 Syndicated Modules

8.3.1 Overview

8.3.2 Syndicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Dedicated Modules

8.4.1 Overview

8.4.2 Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

9.1 Overview

9.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

9.3 Cardiovascular Disorders

9.3.1 Overview

9.3.2 Cardiovascular Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Oncology

9.4.1 Overview

9.4.2 Oncology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Metabolic Disorders

9.5.1 Overview

9.5.2 Metabolic Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Neurology

9.6.1 Overview

9.6.2 Neurology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.7 Orthopaedic Diseases

9.7.1 Overview

9.7.2 Orthopedic Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.8 Infectious Diseases

9.8.1 Overview

9.8.2 Infectious Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

10.1 Overview

10.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

10.3 Biopharmaceutical Companies

10.3.1 Overview

10.3.2 Biopharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10.4 Pharmaceutical Companies

10.4.1 Overview

10.4.2 Pharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Pharmaceutical Contract Sales Organizations Market - Country Analysis

11.1 Europe Pharmaceutical Contract Sales Organizations Market, Revenue and Forecast to 2030

11.1.1.1 Europe Pharmaceutical Contract Sales Organizations Market, by Country

11.1.1.2 UK

11.1.1.2.1 UK: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.2.2 UK: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.2.3 UK: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.2.4 UK: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.2.5 UK: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.3 Germany

11.1.1.3.1 Germany: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.3.2 Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.3.3 Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.3.4 Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.3.5 Germany: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.4 France

11.1.1.4.1 France: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.4.2 France: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.4.3 France: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.4.4 France: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.4.5 France: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.5 Italy

11.1.1.5.1 Italy: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.5.2 Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.5.3 Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.5.4 Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.5.5 Italy: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.6 Spain

11.1.1.6.1 Spain: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.6.2 Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.6.3 Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.6.4 Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.6.5 Spain: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.7 Rest of Europe

11.1.1.7.1 Rest of Europe: Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.7.2 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.7.3 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.7.4 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.7.5 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

12.1 Overview

12.2 Growth Strategies

12.2.1 Overview

13. Company Profiles

13.1 MaBico SA

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 IQVIA Holdings Inc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Syneos Health Inc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Aenova Holding GmbH

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Pfizer Inc

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

14. Appendix

14.1 About Us

14.2 Glossary of Terms

List of Tables

Table 1. Europe Pharmaceutical Contract Sales Organizations Market Segmentation

Table 2. UK: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 3. UK: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 4. UK: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 5. UK: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 6. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 7. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 8. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 9. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 10. France: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 11. France: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 12. France: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 13. France: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 15. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 16. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 17. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 18. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 19. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 20. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 21. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 22. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 23. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 24. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 25. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 26. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market

Table 27. Glossary of Terms, Europe Pharmaceutical Contract Sales Organizations Market

List of Figures

Figure 1. Europe Pharmaceutical Contract Sales Organizations Market Segmentation, By Country

Figure 2. Europe PEST Analysis

Figure 3. Europe Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. Europe Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

Figure 6. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

Figure 7. Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Non-Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

Figure 10. Syndicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

Figure 13. Cardiovascular Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Oncology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Metabolic Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Neurology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Orthopedic Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Infectious Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Others: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

Figure 21. Biopharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Pharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Europe Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)

Figure 24. Europe Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)

Figure 25. UK: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26. Germany: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 27. France: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 28. Italy: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 29. Spain: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 30. Rest of Europe: Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

1. Aenova Holding GmbH

2. IQVIA Holdings Inc

3. MaBico SA

4. Pfizer Inc

5. Syneos Health Inc

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Pharmaceutical Contract Sales Organizations Market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the Europe Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3550

$2840

Site License

$4550

$3640

Enterprise License

$5550

$4440

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Get Free Sample For Europe Pharmaceutical Contract Sales Organizations Market

WHAT'S INCLUDED IN FULL REPORT